Market Access ISPOR Glasgow with EVERSANA: Perspectives on JCA, PICO, and ... At ISPOR EU 2025, a cross-stakeholder panel addressed how Joint Clinical Assessment under the EU HTA Regulation is reshaping evidence strategies.
Patients The ins and outs of HEOR – A lever for global health Web editor Nicole Raleigh speaks with Rob Abbott, CEO and executive director of ISPOR, about the ins and outs and trends of HEOR.
Partner Content Partner Content KANTAR HEALTH'S JESSICA SANTOS TO RECEIVE ISPOR SERVICE AWAR... NEW YORK, May 23, 2018 – Jessica Santos, Global Compliance and Quality Director at Kantar Health, received an ISPOR service award for her contributions to ISPOR's recent updates to its Code of Ethi
News RNAi biotech City hauls in $200m in upsized IPO City Therapeutics has finalised its IPO, raising $200 million for a pipeline of RNA interference therapies headed by a novel anticoagulant.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.